MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 24 2020 - 5:15PM
MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an
industry leader in advanced wound care and a therapeutic biologics
company, today announced that Timothy R. Wright, Chief Executive
Officer, and Peter M. Carlson, Chief Financial Officer, will
present at the Piper Sandler 32nd Annual Virtual Healthcare
Conference taking place December 1-3, 2020.
A pre-recorded presentation will be available on
the Events page of the Investors section of the Company’s website
at www.mimedx.com beginning on November 25, 2020 at 5:00 PM Eastern
Time and will be accessible for approximately 45 days.
About MiMedxMiMedx® is an
industry leader in advanced wound care and a therapeutic biologics
company developing and distributing human placental tissue
allografts with patent-protected processes for multiple sectors of
healthcare. The Company processes the human placental tissue
utilizing its proprietary PURION® process methodology, among
other processes, to produce allografts by employing aseptic
processing techniques in addition to terminal sterilization. MiMedx
has supplied more than two million allografts, through both direct
and consignment shipments. For additional information, please
visit www.mimedx.com.
ContactHilary DixonInvestor
Relations & Corporate
Communications770.651.9066investorrelations@mimedx.com
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From Apr 2023 to Apr 2024